ArticleCanadian Urological Association journal = Journal de l'Association des urologues du Canada2025
GreenLight laser prostatectomy: Are outcomes sustainable after a decade of surgery? A single-center experience with up to 15 years' followup.
Article in Canadian Urological Association journal = Journal de l'Association des urologues du Canada, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionHerein, we report our single-center experience with long-term outcomes over a period of 15 years.
methodsBetween 2005 and 2020, a prospectively maintained database for patients undergoing GreenLight photoselective vaporization of the prostate (PVP) for symptomatic benign prostatic hyperplasia (BPH) was reviewed. Three generations of GreenLight laser were used over this period. Patients with ≥10 years of followup were included. Demographic and perioperative data were collected, including International Prostate Symptom Score (IPSS), quality of life (QoL), peak flow rate (Qmax), postvoid residual urine (PVR), and prostate-specific antigen (PSA) changes. Perioperative and late adverse events were also recorded.
resultsA total of 712 patients with a mean age of 73.9±7.8 years were included in the study, with a median followup of 12.1 years and a mean preoperative prostate size of 72.4±15.3 mL. There were significant reductions in mean IPSS, QoL, and PVR (60.4%, 65%, and 72.6%, respectively; all p<0.001) at the most recent followup compared to baseline values. Likewise, a significant improvement in Qmax (8.2 to 17.7 ml/sec, p<0.001) and a PSA reduction of 64.2% were noted at the most recent followup. The blood transfusion rate was 1.5 %. Transient postoperative dysuria was encountered in 44 (6.2%) patients. Development of bladder neck contracture and urethral stricture were encountered in 18 (2.5%) and 15 (2.1%) patients, respectively. Twenty-four (3.37%) patients required repeat surgery for adenoma regrowth.
conclusionsOur long-term functional outcomes support the durability of the GreenLight laser PVP, with acceptable long-term adverse events after a decade of surgery.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.